341 related articles for article (PubMed ID: 24307739)
21. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
22. cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection.
Lio CW; McDonald B; Takahashi M; Dhanwani R; Sharma N; Huang J; Pham E; Benedict CA; Sharma S
J Virol; 2016 Sep; 90(17):7789-97. PubMed ID: 27334590
[TBL] [Abstract][Full Text] [Related]
23. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.
Walker MM; Crute BW; Cambier JC; Getahun A
J Immunol; 2018 Nov; 201(9):2641-2653. PubMed ID: 30282750
[TBL] [Abstract][Full Text] [Related]
24. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses.
Huang L; Li L; Lemos H; Chandler PR; Pacholczyk G; Baban B; Barber GN; Hayakawa Y; McGaha TL; Ravishankar B; Munn DH; Mellor AL
J Immunol; 2013 Oct; 191(7):3509-13. PubMed ID: 23986532
[TBL] [Abstract][Full Text] [Related]
25. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
[TBL] [Abstract][Full Text] [Related]
26. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes.
Cerboni S; Jeremiah N; Gentili M; Gehrmann U; Conrad C; Stolzenberg MC; Picard C; Neven B; Fischer A; Amigorena S; Rieux-Laucat F; Manel N
J Exp Med; 2017 Jun; 214(6):1769-1785. PubMed ID: 28484079
[TBL] [Abstract][Full Text] [Related]
28. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.
Lavelle EC; McNeela E; Armstrong ME; Leavy O; Higgins SC; Mills KH
J Immunol; 2003 Sep; 171(5):2384-92. PubMed ID: 12928385
[TBL] [Abstract][Full Text] [Related]
29. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
[TBL] [Abstract][Full Text] [Related]
30. cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following
Li Q; Liu C; Yue R; El-Ashram S; Wang J; He X; Zhao D; Zhou X; Xu L
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791397
[TBL] [Abstract][Full Text] [Related]
31. Anti-Cancer Drug HMBA Acts as an Adjuvant during Intracellular Bacterial Infections by Inducing Type I IFN through STING.
Gamage AM; Lee KO; Gan YH
J Immunol; 2017 Oct; 199(7):2491-2502. PubMed ID: 28827286
[TBL] [Abstract][Full Text] [Related]
32. Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines.
Wu JJ; Li WH; Chen PG; Zhang BD; Hu HG; Li QQ; Zhao L; Chen YX; Zhao YF; Li YM
Chem Commun (Camb); 2018 Aug; 54(69):9655-9658. PubMed ID: 30101273
[TBL] [Abstract][Full Text] [Related]
33. A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Svindland SC; Pedersen GK; Pathirana RD; Bredholt G; Nøstbakken JK; Jul-Larsen Å; Guzmán CA; Montomoli E; Lapini G; Piccirella S; Jabbal-Gill I; Hinchcliffe M; Cox RJ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1181-93. PubMed ID: 23170900
[TBL] [Abstract][Full Text] [Related]
34. Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
Ebensen T; Libanova R; Schulze K; Yevsa T; Morr M; Guzmán CA
Vaccine; 2011 Jul; 29(32):5210-20. PubMed ID: 21619907
[TBL] [Abstract][Full Text] [Related]
35. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
36. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
Vasilakos JP; Smith RM; Gibson SJ; Lindh JM; Pederson LK; Reiter MJ; Smith MH; Tomai MA
Cell Immunol; 2000 Aug; 204(1):64-74. PubMed ID: 11006019
[TBL] [Abstract][Full Text] [Related]
38. Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation.
Luo Z; Liang X; He T; Qin X; Li X; Li Y; Li L; Loh XJ; Gong C; Liu X
J Am Chem Soc; 2022 Sep; 144(36):16366-16377. PubMed ID: 36037283
[TBL] [Abstract][Full Text] [Related]
39. Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING.
Panchanathan R; Liu H; Xin D; Choubey D
Innate Immun; 2014 Oct; 20(7):751-9. PubMed ID: 24131791
[TBL] [Abstract][Full Text] [Related]
40. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
